Last updated on August 2018

Asthma Study, Mild to Moderate Asthma. 28 Day Study Inhaler.


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acute Respiratory Distress Syndrome (ARDS) | Asthma | Lung Disease
  • Age: Between 12 - 65 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Male or female subjects must be 12 years of age or older
  • Have persistent asthma, as defined by the National Asthma Education and Prevention Program, for at least 12 weeks before Visit 1 (screening)
  • Be current non-smokers; have not used tobacco products (e.g., cigarettes, e-cigarettes, cigars, pipe tobacco) within the past year (prior to Visit 1[screening])
  • Be able to discontinue controller asthma medication (including LTM, ICS and long-acting β-agonists (LABAs]) during the Run-in Period and Treatment Period.

Note: These are not the only eligibility criteria for this clinical research study, and other criteria may exclude you. A clinical research team member will help determine if you meet all necessary criteria to participate.

ClinicalTrials.gov identifier (NCT number): NCT03535870

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.